Prestige Biologics Co., Ltd. (KOSDAQ: 334970)
South Korea
· Delayed Price · Currency is KRW 5,860.00
+320.00 (5.78%)
Sep 11, 2024, 10:55 AM KST
Prestige Biologics Revenue
In the fiscal year ending June 30, 2023, Prestige Biologics had annual revenue of 1.75B KRW with 11,115.88% growth. Prestige Biologics had revenue of 638.83M in the quarter ending March 31, 2024, with 1,092.69% growth.
Revenue
1.75B
Revenue Growth
-43.26%
P/S Ratio
194.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
356.09B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition